Abstract |
Hepatitis B virus infection is responsible for both morbidity and mortality in kidney transplant recipients. Adenine arabinoside 5'-monophosphate ( ARA-AMP), a synthetic purine nucleotide with anti-viral activity, leads to a sustained interruption of HBV replication in approximately 40% of immunocompetent patients. We report the results of a pilot study using ARA-AMP to treat HBV-related chronic active hepatitis in kidney transplant recipients. Ten patients (2 females and 8 males, mean age 44 years, mean time post- transplantation 163 months) received a 28-day course of ARA-AMP intramuscularly: 5 mg/kg twice daily for the first 5 days during hospitalization and subsequently 5 mg/kg once daily at home for the remaining 23 days. Mean follow-up was 18 months, ranging from 7 to 28 months. All patients but one had biopsy-proven chronic hepatitis, including five cases of cirrhosis. All patients had been chronic HBs Ag carriers for more than 1 year and had active replication as assessed by the presence of serum HBV DNA (mean titre, 270 pg/ml, ranging from 12 to 997 pg/ml, Genostics method). HBe Ag was present in 7 of the 10 patients. Pretreatment creatinine was normal. In four of the 10 patients, HBV DNA became undetectable respectively 1, 1, 5, and 11 months after beginning ARA-AMP. In five patients, HBV DNA decreased during ARA-AMP therapy but subsequently increased although no change was noted during the follow-up period.(ABSTRACT TRUNCATED AT 250 WORDS)
|
Authors | S Pol, C Saltiel, C Legendre, F Carnot, F Driss, P Berthelot, C Bréchot, C Ruet, H Kreis |
Journal | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
(Nephrol Dial Transplant)
Vol. 9
Issue 7
Pg. 820-3
( 1994)
ISSN: 0931-0509 [Print] England |
PMID | 7526277
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- DNA, Viral
- Vidarabine Phosphate
|
Topics |
- Adult
- DNA, Viral
(blood)
- Enzyme-Linked Immunosorbent Assay
- Female
- Hepatitis B
(drug therapy, virology)
- Hepatitis B virus
(drug effects)
- Hepatitis, Chronic
(drug therapy, virology)
- Humans
- Kidney Transplantation
- Male
- Pilot Projects
- Vidarabine Phosphate
(therapeutic use)
|